Taking innovations to industrial scale

Siegfried is a leading contract development and manufacturing organization with a global network of 13 production sites on three continents. With 150 years of pharmaceutical and chemical experience, we are taking your innovations to industrial scale.

Our company

Expect to grow

Visit our careers page

Our offering

As a globally leading contract development and manufacturing organization, we produce pharmaceutical ingredients and finished products as an integrated supplier.

Bringing together our long-standing pharma and chemical heritage

Latest news

Ad hoc

Media Release Jul 10, 2024

Marcel Imwinkelried appointed as new CEO

Media Release Jul 02, 2024

Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)

Ad hoc

Media Release Jun 14, 2024

EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 6.2% registered shares

Ad hoc

Media Release Jun 12, 2024

Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering

Media Release Apr 18, 2024

Siegfried increases distribution to the shareholders and all proposals of the Board of Directors are approved

Ad hoc

Media Release Apr 02, 2024

Changes in Siegfried’s Management Team

Ad hoc

Media Release Feb 20, 2024

Siegfried continues to deliver profitable growth

Media Release Feb 02, 2024

Changes in Siegfried’s Senior Management Team

Media Release Dec 13, 2023

Siegfried confirmed in the Dow Jones Sustainability Index Europe for the third consecutive year

Ad hoc

Media Release Aug 17, 2023

Siegfried delivers strong sales growth and profitability in first half 2023

Media Release May 15, 2023

Changes in Siegfried’s Executive Committee

Ad hoc

Media Release May 04, 2023

Siegfried acquires majority stake in DINAMIQS to establish a best-in-class development and manufacturing organization for cell and gene therapies